Skip to content

Clinical trials

Suspended Multiple Sclerosis, Relapsing-Remitting trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Suspended Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20211
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Emerald Health Pharmaceuticals1
Hoffmann-La Roche1
ProgenaBiome1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis3
Multiple Sclerosis, Relapsing-Remitting3
Acne Vulgaris1
Alzheimer Disease1
Amyotrophic Lateral Sclerosis1
Anxiety Disorders1
Arthritis, Rheumatoid1
Autism Spectrum Disorder1
Autistic Disorder1
Autoimmune Diseases of the Nervous System1

Trials

Showing 51 to 3 of 3. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.